Background: The Abelson oncogene was initially identified as the viral transforming component of Abelson murine leukemia virus (A-MuLV). The Abelson gene (ABL1) encodes a SH2-domain bearing tyrosine kinase which conducts mitogenic signaling pursuant to growth factor receptor ligation. The Abl interactor proteins, Abi-1, Abi-2 and Abi-3, are SH3-domain containing proteins that bind to the proline-rich motifs of Abl and activate the kinase function. The Abi family members are thought to negatively regulate cell growth and transformation, including cellular transformation through v-Abl as well as mediate cell motility by regulating actin polymerization in lamellipodia and filopodia. Abi-3, also designated NESH, is a 366 amino acid protein that interacts with TARSH, a cellular senescence-related gene that acts as a trigger of tumor development.
Description: Rabbit polyclonal to ABI3
Immunogen: KLH conjugated synthetic peptide derived from ABI3
Specificity: ·Reacts with Human, Mouse, Pig, Dog and Rat.
·Isotype: IgG
Application: ·Western blotting: 1/100-500. Predicted Mol wt: 39 kDa;
·Immunohistochemistry (Paraffin/frozen tissue section): 1/50-200;
·Immunocytochemistry/Immunofluorescence: 1/100;
·Immunoprecipitation: 1/50;
·ELISA: 1/500;
·Optimal working dilutions must be determined by the end user.
